A 60-week real-world experience with guselkumab in patients with moderate-to-severe plaque psoriasis including patients with malignancy: A retrospective study from Ontario, Canada

A 60-week real-world experience with guselkumab in patients with moderate-to-severe plaque psoriasis including patients with malignancy: A retrospective study from Ontario, Canada

Bibliographic Details
Main Authors: Manal Al-Rabai, Lujain Al-Ghanemi, Julia Steriopoulos, Ahmad Saleem, Mohannad Abu-Hilal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Journal of Dermatology and Dermatologic Surgery
Online Access:http://www.jddsjournal.org/article.asp?issn=2352-2410;year=2023;volume=27;issue=2;spage=90;epage=92;aulast=Al-Rabai

Internet

http://www.jddsjournal.org/article.asp?issn=2352-2410;year=2023;volume=27;issue=2;spage=90;epage=92;aulast=Al-Rabai

Similar Items